GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Net Cash Flow came in at -$1.8 million in Q4 2025, down 796.23% on a YoY basis from $261720.6 in Q4 2024, and down 184.0% quarter-over-quarter from $2.2 million in Q3 2025.

Analysis

GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has reported Net Cash Flow for 11 consecutive years, with -$1.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 796.23% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at $173614.0 (up 104.89% YoY), and the FY2025 full-year result was $510041.0, up 114.37% from the prior year.
  • Net Cash Flow slipped to -$1.8 million in Q4 2025 per GRDX's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.0 million in Q1 2021 and bottomed at -$4.5 million in Q2 2022.
  • Historically, Net Cash Flow has averaged -$248728.9 across 5 years, with a median of -$160975.5 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 1451.13% in 2023, then slumped 796.23% in 2025.
  • Over 5 years, Net Cash Flow stood at $962029.0 in 2021, then tumbled by 107.07% to -$68050.0 in 2022, then surged by 1451.13% to $919444.0 in 2023, then tumbled by 122.11% to -$203316.0 in 2024, then slumped by 796.23% to -$1.8 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$1.8 million, $2.2 million, and -$54878.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -170.75 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.82 Mn
Sep 30, 2025 2.17 Mn
Jun 30, 2025 -54,878.00
Mar 31, 2025 -118,635.00
Dec 31, 2024 -203,316.00
Sep 30, 2024 -295,687.00
Jun 30, 2024 -2.77 Mn
Mar 31, 2024 -279,857.00
Dec 31, 2023 919,444.00
Sep 30, 2023 2.06 Mn
Jun 30, 2023 -828,380.00
Mar 31, 2023 701,530.00
Dec 31, 2022 -68,050.00
Sep 30, 2022 517,661.00
Jun 30, 2022 -4.51 Mn
Mar 31, 2022 -2.54 Mn
Dec 31, 2021 962,029.00
Sep 30, 2021 -868,786.00
Jun 30, 2021 -3.91 Mn
Mar 31, 2021 5.98 Mn